HC Wainwright & Co. Reiterates Buy on Rallybio, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Rallybio (NASDAQ:RLYB) and maintained a price target of $6, indicating confidence in the company's potential.
September 03, 2024 | 10:46 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Rallybio and maintained a $6 price target, suggesting confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $6 price target by HC Wainwright & Co. indicates a positive outlook on Rallybio's stock. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100